Holen Sie sich die Stockscreener-App
50.09
1.37%
0.6323
Finanzdaten der Ptc Therapeutics Inc-Aktie (PTCT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
84.79%
178.88
|
1,176.10 | 196.79 | 186.70 | 210.12 |
Operating Expenses
|
3.87%
213.83
|
205.87 | 251.30 | 226.92 | 255.57 |
| Benefits Costs and Expenses |
1.49%
249.93
|
246.27 | 294.78 | 272.44 | 294.81 |
| Costs And Expenses |
1.49%
249.93
|
246.27 | 294.78 | 272.44 | 294.81 |
| Operating Income/Loss |
103.60%
-34.96
|
970.23 | -54.51 | -40.22 | -45.45 |
| Income/Loss From Continuing Operations Before Tax |
107.64%
-71.05
|
929.83 | -97.99 | -85.73 | -84.70 |
| Income Tax Expense/Benefit |
109.80%
-6.203
|
63.27 | 8.663 | 13.45 | 6.88 |
| Income/Loss From Continuing Operations After Tax |
107.48%
-64.85
|
866.56 | -106.65 | -99.18 | -91.58 |
|
Net Income/Loss
|
107.48%
-64.85
|
866.56 | -106.65 | -99.18 | -91.58 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.05%
78.15
|
78.12 | 76.93 | 76.73 | 76.50 |
| Diluted Average Shares |
9.53%
78.15
|
86.39 | 76.93 | 76.73 | 76.50 |
| Basic Earnings Per Share |
107.48%
-0.83
|
11.09 | -1.39 | -1.29 | -1.20 |
| Diluted Earnings Per Share |
108.27%
-0.83
|
10.04 | -1.39 | -1.29 | -1.20 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.04%
7.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):